Zinc transporter 8 (ZnT8) autoantibody epitope specificity and affinity examined with recombinant ZnT8 variant proteins in specific ZnT8R and ZnT8W autoantibody-positive type 1 diabetes patients

Clinical and Experimental Immunology

Volumn 179, Issue 2, 2015, Pages 220-229

  Skarstrand H ^a   Krupinska, E ^b   Haataja, T J K ^b   Vaziri Sani, F ^a   Lagerstedt, J O ^b   Lernmark, Å ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Autoantibody affinity; Autoimmune diabetes; Epitope analysis; Polymorphic residue; ZnT8 autoantibodies

Indexed keywords

AUTOANTIBODY; CATION TRANSPORT PROTEIN; EPITOPE; RECOMBINANT PROTEIN; SLC30A8 PROTEIN, HUMAN;

ADOLESCENT; ADULT; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; BLOOD; CHEMISTRY; CHILD; CLINICAL TRIAL; FEMALE; HUMAN; IMMUNOLOGY; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRESCHOOL CHILD;

ADOLESCENT; ADULT; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; AUTOANTIBODIES; CATION TRANSPORT PROTEINS; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; EPITOPES; FEMALE; HUMANS; INFANT; MALE; RECOMBINANT PROTEINS;

EID: 84920275601     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12448     Document Type: Article

References (34)

1. Richardson SJ, Willcox A, Bone AJ, Morgan NG, Foulis AK. Immunopathology of the human pancreas in type-I diabetes. Semin Immunopathol 2011; 33:9-21.
2. Pugliese A, Yang M, Kusmarteva I etal. The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: goals, operational model and emerging findings. Pediatr Diabetes 2014; 15:1-9.
3. Wong FS, Wen L. B cells in autoimmune diabetes. Rev Diabet Stud 2005; 2:121-135.
4. Wenzlau JM, Frisch LM, Gardner TJ, Sarkar S, Hutton JC, Davidson HW. Novel antigens in type 1 diabetes: the importance of ZnT8. Curr Diab Rep 2009; 9:105-112.
5. Kulmala P, Savola K, Petersen JS etal. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group. J Clin Invest 1998; 101:327-336.
6. Taplin CE, Barker JM. Autoantibodies in type 1 diabetes. Autoimmunity 2008; 41:11-18.
7. Winter WE, Schatz DA. Autoimmune markers in diabetes. Clin Chem 2011; 57:168-175.
8. Wenzlau JM, Juhl K, Yu L etal. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci USA 2007; 104:17040-17045.
9. Arvan P, Pietropaolo M, Ostrov D, Rhodes CJ. Islet autoantigens: structure, function, localization, and regulation. Cold Spring Harb Perspect Med 2012; 2. doi: 10.1101/cshperspect.a007658.
10. Gardner SG, Gale EA, Williams AJ etal. Progression to diabetes in relatives with islet autoantibodies. Is it inevitable? Diabetes Care 1999; 22:2049-2054.
11. Elding Larsson H, Vehik K, Gesualdo P etal. Children followed in the TEDDY study are diagnosed with type 1 diabetes at an early stage of disease. Pediatr Diabetes 2014; 15:118-126.
12. Schroer JA, Bender T, Feldmann RJ, Kim KJ. Mapping epitopes on the insulin molecule using monoclonal antibodies. Eur J Immunol 1983; 13:693-700.
13. Achenbach P, Koczwara K, Knopff A, Naserke H, Ziegler AG, Bonifacio E. Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes. J Clin Invest 2004; 114:589-597.
14. Kanatsuna N, Papadopoulos GK, Moustakas AK, Lenmark A. Etiopathogenesis of insulin autoimmunity. Anat Res Int 2012; 2012:457546.
15. Schwartz HL, Chandonia JM, Kash SF etal. High-resolution autoreactive epitope mapping and structural modeling of the 65kDa form of human glutamic acid decarboxylase. J Mol Biol 1999; 287:983-999.
16. Elvers KT, Geoghegan I, Shoemark DK, Lampasona V, Bingley PJ, Williams AJ. The core cysteines (C909) of islet antigen-2 and (C945) of islet antigen-2beta, are crucial to autoantibody binding in type 1 diabetes. Diabetes 2013; 62:214-222.
17. Kawasaki E, Sera Y, Abiru N etal. Distinct IA-2 autoantibody epitope recognition between childhood-onset and adult-onset type 1 diabetes. Ann NY Acad Sci 2002; 958:235-240.
18. Wenzlau JM, Liu Y, Yu L etal. A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes. Diabetes 2008; 57:2693-2697.
19. Vaziri-Sani F, Delli AJ, Elding-Larsson H etal. A novel triple mix radiobinding assay for the three ZnT8 (ZnT8-RWQ) autoantibody variants in children with newly diagnosed diabetes. J Immunol Methods 2011; 371:25-37.
20. Achenbach P, Lampasona V, Landherr U etal. Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk. Diabetologia 2009; 52:1881-1888.
21. Andersson C, Carlsson A, Cilio C etal. Glucose tolerance and beta-cell function in islet autoantibody-positive children recruited to a secondary prevention study. Pediatr Diabetes 2013; 14:341-349.
22. Sladek R, Rocheleau G, Rung J etal. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007; 445:881-885.
23. Gohlke H, Ferrari U, Koczwara K, Bonifacio E, Illig T, Ziegler AG. SLC30A8 (ZnT8) Polymorphism is associated with young age at type 1 diabetes onset. Rev Diabet Stud 2008; 5:25-27.
24. Concannon P, Rich SS, Nepom GT. Genetics of type 1A diabetes. N Engl J Med 2009; 360:1646-1654.
25. Wenzlau JM, Moua O, Liu Y, Eisenbarth GS, Hutton JC, Davidson HW. Identification of a major humoral epitope in Slc30A8 (ZnT8). Ann NY Acad Sci 2008; 1150:252-255.
26. Kawasaki E, Uga M, Nakamura K etal. Association between anti-ZnT8 autoantibody specificities and SLC30A8 Arg325Trp variant in Japanese patients with type 1 diabetes. Diabetologia 2008; 51:2299-2302.
27. Wenzlau JM, Frisch LM, Hutton JC, Davidson HW. Mapping of conformational autoantibody epitopes in ZNT8. Diabetes Metab Res Rev 2011; 27:883-886.
28. Skarstrand H, Lernmark A, Vaziri-Sani F. Antigenicity and epitope specificity of ZnT8 autoantibodies in type 1 diabetes. Scand J Immunol 2013; 77:21-29.
29. Delli AJ, Vaziri-Sani F, Lindblad B etal. Zinc transporter 8 autoantibodies and their association with SLC30A8 and HLA-DQ genes differ between immigrant and Swedish patients with newly diagnosed type 1 diabetes in the Better Diabetes Diagnosis study. Diabetes 2012; 61:2556-2564.
30. Vaziri-Sani F, Oak S, Radtke J etal. ZnT8 autoantibody titers in type 1 diabetes patients decline rapidly after clinical onset. Autoimmunity 2010; 43:598-606.
31. Hampe CS, Ortqvist E, Rolandsson O etal. Species-specific autoantibodies in type 1 diabetes. J Clin Endocrinol Metab 1999; 84:643-648.
32. Mayr A, Schlosser M, Grober N etal. GAD autoantibody affinity and epitope specificity identify distinct immunization profiles in children at risk for type 1 diabetes. Diabetes 2007; 56:1527-1533.
33. Sosenko JM, Skyler JS, Palmer JP etal. The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients. Diabetes Care 2013; 36:2615-2620.
34. Hagopian WA, Erlich H, Lernmark A etal. The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421000 infants. Pediatr Diabetes 2011; 12:733-743.